Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

11.38p
   
  • Change Today:
    -0.25p
  • 52 Week High: 17.75p
  • 52 Week Low: 9.90p
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 415,854
  • Market Cap: £46.92m

Latest Deals

Traded Action Notifier PriceAmountValue
13-Jan-26 Transfer From Richard John Rees 0.000p 16,072 £0.00
13-Jan-26 Buy Richard John Rees 11.20p 8,036 £900.03
13-Jan-26 Transfer From Craig Jonathan Gulliford 0.000p 16,072 £0.00
13-Jan-26 Buy Craig Jonathan Gulliford 11.20p 8,036 £900.03
08-Aug-25 Transfer To Richard John Rees 0.000p 362,408 £0.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
13-Jan-26 Buy Craig Jonathan Gulliford 11.20p 8,036 £900.03
13-Jan-26 Buy Richard John Rees 11.20p 8,036 £900.03

Director Shareholdings

Notifier Holding Value*
Kevin Crofton 5,447,416 £619,644
Richard John Rees 2,723,627 £309,813
Craig Jonathan Gulliford 1,703,873 £193,816
Ivonne Cantu 125,000 £14,219

Major Shareholders

Notifier** Holding Value*
M&G Investments 49,583,836 £5,640,161
Canaccord Genuity Group Inc 36,167,753 £4,114,082
Baillie Gifford & Co 27,795,238 £3,161,708
Hargreave Hale Limited 22,846,245 £2,598,760
River Global Investors LLP 20,827,081 £2,369,080
AXA Framlington Investment Managers 17,066,645 £1,941,331
Amati Global Investors 15,959,536 £1,815,397
Development Bank of Wales plc 14,376,727 £1,635,353
Finance Wales 14,376,727 £1,635,353
Creo Medical Group EBT 10,000,000 £1,137,500
The Capital Group Companies, Inc. 8,816,807 £1,002,912
Tellworth Investments 5,772,778 £656,654
Hoya Corporation 4,799,880 £545,986
Jonathan Craton 3,400,294 £386,783
Cotterford Co Limited 3,335,398 £379,402
Mark Farmer 3,121,607 £355,083
RBC Trustees (CI) Ltd 2,974,727 £338,375
Angel Co Fund 2,967,120 £337,510

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 11.38p
Change Today -0.25p
% Change -2.15 %
52 Week High 17.75p
52 Week Low 9.90p
Volume 415,854
Shares Issued 412.47m
Market Cap £46.92m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 20-May-2026

Time Volume / Share Price
16:11 43,668 @ 11.45p
12:42 7,551 @ 11.25p
12:33 4,314 @ 11.45p
12:27 10,445 @ 11.45p
11:18 250,000 @ 11.25p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
Chair Kevin Crofton

Top of Page